Acute Gastroenteritis with Consideration for COVID-19
This presentation is most consistent with acute viral gastroenteritis, and initial management should focus on oral rehydration and symptomatic care, with COVID-19 testing warranted given the combination of gastrointestinal and respiratory symptoms.
Most Likely Diagnosis
Acute viral gastroenteritis is the most probable diagnosis in this 45-year-old woman presenting with one day of headache, nausea, diarrhea, bloating, and non-productive cough 1, 2. The yellow foul-smelling stools suggest malabsorption or rapid transit typical of viral enteritis 1. However, the constellation of GI symptoms combined with cough raises important consideration for COVID-19, which presents with GI manifestations in 11-37% of cases 1.
Key Diagnostic Considerations
- Viral gastroenteritis accounts for the majority of acute diarrheal illness in adults, with norovirus being the leading pathogen (58% of cases) 1
- COVID-19 should be strongly considered given that 21 patients in one cohort lacked respiratory symptoms entirely and presented only with GI symptoms 1
- The presence of diarrhea with cough in COVID-19 patients is associated with significantly worse outcomes, including 2.75 times higher mortality risk 3
- Yellow foul-smelling stools without blood make bacterial dysentery (Shigella, Campylobacter) or inflammatory causes less likely 1
Initial Assessment Priorities
Clinical Evaluation
Assess for dehydration severity by examining:
- Vital signs focusing on orthostatic changes, tachycardia, and blood pressure 1
- Mucous membrane moisture, skin turgor, and mental status 1
- Urine output and concentration 1
Screen for inflammatory/invasive features:
- Fever >38.5°C suggests bacterial or severe viral illness 1
- Blood in stool would indicate inflammatory diarrhea requiring different management 1
- Severe abdominal pain out of proportion to exam findings could suggest ischemia 4
Measure oxygen saturation at rest - this is the single most important vital sign if COVID-19 is suspected, as SpO₂ <93% defines moderate-to-severe disease 5
Laboratory Testing Strategy
Most patients with acute watery diarrhea do NOT require laboratory workup 1, 2. However, testing is indicated if:
- Fever with bloody diarrhea is present 1
- Symptoms persist beyond 7 days 1, 6
- Severe dehydration or immunosuppression exists 1, 2
- COVID-19 is suspected based on epidemiologic or clinical factors 5, 7
If testing is warranted, obtain:
- COVID-19 RT-PCR testing given the combination of GI and respiratory symptoms 1, 5, 7
- Complete blood count if systemic illness is suspected 4
- Stool studies are NOT indicated for simple acute watery diarrhea without fever or blood 1, 2
Initial Management
Rehydration Therapy
Oral rehydration solution (ORS) is first-line therapy for mild to moderate dehydration 1. This patient should:
- Receive reduced-osmolarity ORS as the primary intervention 1
- Resume normal age-appropriate diet immediately after rehydration 1
- Continue oral intake throughout the illness 1
Intravenous fluids (lactated Ringer's or normal saline) are reserved for severe dehydration, shock, altered mental status, or failure of oral rehydration 1
Symptomatic Management
Antimotility agents (loperamide) may be offered to this immunocompetent adult with watery diarrhea 1. However:
Antiemetics (ondansetron) can facilitate oral rehydration if nausea is prominent 1
Probiotics may be offered to reduce symptom duration and severity 1
Antibiotic Therapy
Empiric antibiotics are NOT indicated for this presentation 1, 2. Antibiotics should only be considered if:
- Fever with bloody diarrhea develops (suggesting Shigella, Campylobacter, or Salmonella) 1
- A specific bacterial pathogen is identified on stool culture 1
- The patient becomes severely ill or immunocompromised 1, 2
COVID-19 Specific Considerations
When to Test for COVID-19
COVID-19 testing is warranted in this case because 1, 5, 7:
- GI symptoms (diarrhea, nausea) occur in 11-37% of COVID-19 patients 1
- Diarrhea was present on admission in 6-37% of hospitalized COVID-19 patients 1
- Non-productive cough combined with GI symptoms is a recognized COVID-19 presentation 1
- Patients with GI symptoms may lack typical respiratory symptoms initially 1
Risk Stratification if COVID-19 Confirmed
Monitor closely for disease progression if COVID-19 is confirmed 5:
- Serial oxygen saturation measurements (SpO₂ <93% indicates moderate-to-severe disease) 5
- Respiratory rate assessment (tachypnea suggests respiratory distress) 5
- Consider inflammatory markers (CRP, D-dimer) if admission is being considered 5
Diarrhea in COVID-19 patients predicts worse outcomes 3:
- 2.75 times higher mortality risk 3
- 2.24 times higher ICU admission rate 3
- 3.16 times higher intubation risk 3
Disposition and Follow-Up
Outpatient Management
Most patients can be managed at home if 1, 2:
- Mild dehydration that responds to oral rehydration 1
- No fever or bloody stools 1
- Adequate social support and ability to maintain hydration 1
- Normal oxygen saturation if COVID-19 is suspected 5
Provide clear return precautions:
- Worsening symptoms beyond 48-72 hours 1, 6
- Development of fever, bloody stools, or severe abdominal pain 1
- Inability to maintain hydration 1
- Shortness of breath or chest pain if COVID-19 is possible 5, 7
Hospital Admission Criteria
- Severe dehydration unresponsive to oral rehydration 1
- Altered mental status or shock 1
- Persistent symptoms >20 days in any patient 4
- SpO₂ <93% on room air if COVID-19 is confirmed 5
- Immunosuppression with persistent GI symptoms 4
Critical Pitfalls to Avoid
- Do not dismiss the combination of GI and respiratory symptoms as simple gastroenteritis without considering COVID-19 1, 7
- Do not order routine stool cultures for acute watery diarrhea without fever or blood 1, 2
- Do not prescribe empiric antibiotics for uncomplicated acute watery diarrhea 1, 2
- Do not use antimotility agents if fever or bloody stools develop 1
- Do not rely on symptoms alone to assess COVID-19 severity; measure oxygen saturation objectively 5
- Do not overlook that COVID-19 patients with diarrhea have significantly worse outcomes and may require closer monitoring 3